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STATE-OF-THE-ART REVIEW
3D Printing is a Transformative Technology
in Congenital Heart Disease
Shafkat Anwar, MD,a Gautam K. Singh, MD,a Jacob Miller, MD,b Monica Sharma, MS,a Peter Manning, MD,b
Joseph J. Billadello, MD,c Pirooz Eghtesady, MD, PHD,b Pamela K. Woodard, MDd
SUMMARY
Survival in congenital heart disease has steadily improved since 1938, when Dr. Robert Gross successfully ligated for
the ﬁrst time a patent ductus arteriosus in a 7-year-old child. To continue the gains made over the past 80 years,
transformative changes with broad impact are needed in management of congenital heart disease. Three-dimensional
printing is an emerging technology that is fundamentally affecting patient care, research, trainee education, and
interactions among medical teams, patients, and caregivers. This paper ﬁrst reviews key clinical cases where the
technology has affected patient care. It then discusses 3-dimensional printing in trainee education. Thereafter, the role of
this technology in communication with multidisciplinary teams, patients, and caregivers is described. Finally, the
paper reviews translational technologies on the horizon that promise to take this nascent ﬁeld even further.
(J Am Coll Cardiol Basic Trans Science 2018;3:294–312) © 2018 The Authors. Published by Elsevier on behalf of
the American College of Cardiology Foundation. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
T hree-dimensional (3D) printing is an additivemanufacturing technique with increasing usein health care. As a fabrication technique 3D
printing was recently listed by the McKinsey Global
Institute as a “disruptive technology that will trans-
form life, business and the global economy,”with a po-
tential economic impact of $200 billion to $600 billion
between 2013 and 2025 (1). In health care, adoption of
this technology has been a relatively recent phenome-
non. A recent review found just 2 papers (excluding
case studies and abstracts) in medical publications
before 2000, and that number grew to 189 between
2011 and 2015 (2). Use within cardiology has followed
a similar trend, with growth mainly in the past decade
(3). Vukicevic et al. (4) recently published an excellent
review of cardiac 3D printing focusing primarily on
acquired structural heart disease. In this paper, we
review the transformative role of 3D printing in
congenital heart disease (CHD) (Central Illustration).
SCOPE OF CONGENITAL HEART DISEASE
AND THE NEED FOR TRANSFORMATIVE CARE
The prevalence of CHD is approximately 9 in 1,000
live births (5,6). Survival rates vary by disease
complexity, with long-term survival (>20 years) at
approximately 95% for simple CHD, 90% for moder-
ate complexity, and 80% for severe, complex CHD (7).
Overall survival rates have steadily increased for even
the most complex CHD (8–11), although survival alone
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is not a sufﬁcient outcome measure in the current era.
Other important metrics include the following: long-
term morbidity; reintervention rates; length of hos-
pitalization; neurodevelopmental outcomes; cost to
the health care system; and patient or caregiver
satisfaction. Obtaining the best outcomes requires an
impact at multiple levels, including patients and
caregivers, individual clinicians, the medical team
and the health care system. 3D printing is a disruptive
technology that is affecting each of these key areas in
CHD.
The earliest papers on cardiovascular 3D printing
were published in the early 2000s. Binder et al. (12)
showed feasibility from echocardiographic data in
2000, and Pentacost et al. (13) produced 3D models
replicating cardiac embryology from photomicro-
graphic data in 2001. Soon thereafter, datasets from
computed tomography (CT) or magnetic resonance
imaging (MRI) were used to produce 3D cardiac
models of increasing complexity (14–16), with a
steady rise in publications in the past decade (3).
Figure 1 shows the applications of 3D printing in
medicine, broadly categorized as surgical planning,
education, and manufacturing of custom parts (17).
Given that a 3D model is a replica of a patient’s
anatomy, models may be used for precise pre-surgical
planning and simulation (18–21). Patient-speciﬁc pre-
surgical planning may potentially reduce time spent
in the operating room (OR) and result in fewer com-
plications. In turn, this may lead to shorter post-
operative stays, decreased reintervention rates, and
lower health care costs. Given the relatively recent
use of 3D printing in CHD, there are currently no data
supporting these presumed outcomes. Most of the
evidence in published reports is qualitative, through
case reports and series. Emerging reports from other
surgical subspecialties appear promising. Recent data
from craniofacial reports suggest that 3D printing can
improve outcomes, including saving time in the OR
and thus translating to direct cost savings (22,23).
3D PRINTING TECHNOLOGY AND OPTIONS
FOR CARDIOVASCULAR PRINTING
Several recent publications have described the pro-
cess of medical 3D printing (3,4,24–27), summarized
as these key steps:
1. Acquisition of a high-resolution 3D imaging dataset
2. Segmentation of the anatomy using specialized
post-processing software
3. Computer-aided design to reﬁne the design, add
cut-planes, or include elements required for model
stability
4. Creation of a 3D ﬁle in a format recognized
by the 3D printer, usually in the Surface
Tessellation Language or stereo-
lithography (STL) ﬁle format
5. Printing of the physical model
3D printing technologies may be catego-
rized as photopolymeric (the use of light to
harden a deposited photopolymer), thermo-
plastic (extruding melted thermoplastics in
layers to build up a model), or powder fusion
(a process that fuses ceramic or metal powder
by using an adhesive or laser beam to create a
3D object) (4,24). Printer resolution for
higher-end medical-grade printers is in the
order of micrometers, well within the reso-
lution needed to print cardiac structures.
Figure 2 shows these technologies in detail
(28).
Principally, there are 2 main types of cardiac
models: “blood-pool” and “hollow” models. Blood
pool models are solid 3D representations of the blood
pool within the cardiac chambers and vessels
(Figure 3). They are created by segmenting the blood
pool signal, usually from contrast-enhanced CT or
MRI, after which the 3D object is printed. Non-
cardiovascular structures such as airways or soft tis-
sue may also be included for printing. These models
provide excellent visualization of the great vessels,
extracardiac vasculature, and surrounding structures
such as airways or the esophagus. The drawback of
these types of models is their limited views of intra-
cardiac anatomy.
Hollow models are created by applying a mesh
representing myocardium and vessel walls around
the blood pool signal and then digitally removing the
blood pool signal to show the intracardiac cavities.
The end result is a hollow model showing the intra-
cardiac anatomy in detail. These models are usually
sectioned along a pre-determined cut-plane with 2 or
more sections showing the intracardiac anatomy, as
shown in Figure 4.
A subtype of the hollow models consists of intact
hollow models. These models also show the intra-
cardiac anatomy but are printed intact (i.e., without a
cut-plane), thereby resulting in the most accurate
representation of the heart as it sits in the chest.
When printed in a ﬂexible material, these models
allow cardiothoracic surgeons to use standard
surgical approaches and see the anatomy from a
“surgeon’s perspective,” as they would for the actual
case (Figures 5A and 5B). Thus, these models are ideal
for surgical simulation, especially when they are
printed in materials that can be cut, can hold suture,
AB BR E V I A T I O N S
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and can allow engraftment of foreign materials
(e.g., patch, cannula).
APPLICATIONS OF 3D PRINTING IN CHD
Several publications have described the use of 3D
printing in CHD, spanning the spectrum from atrial or
ventricular septal defects (ASDs, VSDs) (29,30) to the
most complex cardiac lesions (18,21,25,31–36). Pub-
lished reports have been summarized in a recent
textbook on cardiac 3D printing (24).
A selection of cases is now reviewed to show the
main applications of 3D printing in CHD. These cases
were selected from a cohort of pediatric and adult
patients with CHD at our institution who underwent
3D printing. For the complete list of cases, please
refer to Supplemental Table 1. Most of these cases
were printed for surgical planning and simulation;
others with unique or rare anatomy were printed for
trainee education. The majority of cases had complex
CHD, with a median complexity score of 3 (simple ¼ 1,
moderate ¼ 2, great ¼ 3) (37). Most of the cases prin-
ted for surgical planning were high-risk surgical
candidates, and the median Society of Thoracic
Surgeons-European Association for Cardio-Thoracic
Surgery mortality category (1 to 5) was 4.
CENTRAL ILLUSTRATION Applications of 3D Printing in Congenital Heart Disease
Anwar, S. et al. J Am Coll Cardiol Basic Trans Science. 2018;3(2):294–312.
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PLANNING COMPLEX INTRACARDIAC REPAIR.
Three of 1,000 patients born with CHD require
catheter-based or surgical intervention early in life
(38). Outcomes are signiﬁcantly affected by the
complexity of the underlying anatomy and perioper-
ative factors, including cardiopulmonary bypass time,
ischemic time, or circulatory arrest time (39–43). 3D
models allow the visualization and understanding of
complex spatial relationships and enable precise
pre-surgical planning. A common application in CHD
is planning repair of a double-outlet right ventricle
(DORV) requiring a complex intracardiac bafﬂe. This
is typically a high-risk operation, Society of Thoracic
Surgeons-European Association for Cardio-Thoracic
Surgery category 4 (44). Figure 6 shows this applica-
tion in an 8-month-old (8 kg) patient with a complex
DORV, previously reported by our group (18). The
patient had visceroatrial situs inversus, dextrocardia,
and a DORV with levomalposed great arteries. The
model in Figure 6 demonstrates the key anatomy to
plan a 2-ventricle repair. The patient had a successful
2-ventricle repair consistent with the model-guided
pre-surgical plan. Several other groups have
reported the use of 3D printing to plan complex
intracardiac repairs in patients with multiple VSDs or
DORV (30–32,36).
SURGICAL SIMULATION. The ultimate in pre-surgical
planning using 3D models is one in which a “simu-
lated surgery” is performed, as illustrated by the next
case. The patient was a 3 1/2-year-old male child with
heterotaxy, asplenia syndrome with complex single
ventricle anatomy, and abnormal systemic and
pulmonary venous connections (Figure 7). He had
previously undergone bilateral bidirectional superior
cavopulmonary connections (bilateral Glenn proced-
ure) as part of single ventricle palliation. 3D printing
was performed to plan his next surgery, a total cav-
opulmonary connection (aka Fontan). Two 3D models
were printed; 1 multicolor with an axial cut-plane and
FIGURE 1 Application of 3D Printing in Medicine
Most of these applications pertain to cardiology, except for wearable devices, for which
the authors did not ﬁnd any cardiac-speciﬁc published reports. Adapted with permission
from VanKoevering et al. (17).
FIGURE 2 3D Printing Technologies
ABS¼ acrylonitrile butadiene styrene; CJP¼ color jet printing; Co¼ cobalt; Cr¼ chromium; DLP¼ direct light processing; FDM¼ fused deposition modeling; FFF¼ fused
ﬁlament fabrication; HIPS¼ high impact polystyrene; Ni¼ nickel; PLA¼polylactic acid; PVA¼polyvinyl alcohol; SLA¼ stereolithography apparatus; SLM¼ selective laser
melting; SLS¼ selective laser sintering; Ti¼ titanium; TPE¼ thermoplastic elastomer; TPU¼ thermoplastic urethane. Reproducedwith permission fromBorrello et al. (28).
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a second ﬂexible intact-heart model (no cut-plane) for
surgical simulation. The internal anatomy of both
models was identical. By using the models, detailed
pre-surgical planning was performed. Speciﬁcally, the
models were used to plan placement of the Fontan
conduit (intracardiac or extracardiac) and to evaluate
its relationship with systemic veins and impact on
pulmonary veins. The model was also used to
simulate “plan A,” “plan B,” or “bailout” scenarios,
each with a unique surgical plan. This level of
detailed surgical simulation is not feasible with cur-
rent standard of care (e.g., 3D volumetric rendering),
and it shows the added value of 3D printed models.
Supplemental Video 1 (Figure 7) shows the pre-
surgical planning session for this case with the
cardiothoracic surgeon and cardiologists.
FIGURE 4 Hollow Cardiac 3D Model Showing Intracardiac Anatomy
FIGURE 3 Blood Pool Cardiac 3D Model
Source images on the left show the segmented blood pool signal. The model is shown on the right.
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EXTRACARDIAC AND VASCULAR SURGERY. 3D
printing can be a valuable tool to plan extracardiac
and vascular surgery in patients with CHD. 3D models
are helpful for planning high-risk unifocalization
surgery, as illustrated by the following case.
Figures 8A to 8E show a case of tetralogy of Fallot,
pulmonary atresia, and MAPCAs in a patient with
22q11 deletion (DiGeorge syndrome), with repair un-
dertaken in 3 stages because of high pre-surgical
morbidity in this patient. We previously reported
the ﬁrst stage of this operation done at 10 months of
age (18). Figure 8 shows all 3 stages. The 3D models
show spatial relationships among the aorta,
aortopulmonary collaterals (APCs), pulmonary veins,
and airways that enabled detailed pre-surgical plan-
ning. Precise visualization of the complex relation-
ships between APCs and surrounding structures
enables easier identiﬁcation and surgical manipula-
tion during the case, thereby reducing operative time
and potentially improving the surgical outcome. This
patient underwent a right modiﬁed Blalock-Taussig-
Thomas shunt to the right-sided APCs (Figure 8B),
followed by a left modiﬁed Blalock-Taussig-Thomas
shunt (Figure 8D) and, ultimately, successful uni-
focalization (Figure 8E). 3D printing for pulmonary
atresia and MAPCAs offers signiﬁcant beneﬁts over
FIGURE 6 3D Model of Double-Outlet RV Showing Relationships Among Ventricles, VSD, and Outﬂows
The dashed line indicates the potential ventricular septal defect (VSD) bafﬂe pathway to achieve a 2-ventricle repair. Ao ¼ aorta; LA ¼ left
atrium; LV ¼ left ventricle; RV ¼ right ventricle; SVC ¼ superior vena cava; other abbreviations as in Figure 5.
FIGURE 5 Models for Surgical Planning
(A) Flexible hollow model printed intact with corresponding rigid multicolor model. (B) The “surgeon’s view” through a right atriotomy.
IVC ¼ inferior vena cava; RA ¼ right atrium.
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current standard of care, also described in prior
publications (14,21).
VENTRICULAR ASSIST DEVICE AND HEART TRANSPLANT.
An endpoint of many patients with CHD is heart
failure requiring a ventricular assist device or heart
transplant. 3D printing can aid in ventricular assist
device placement and optimizing function in complex
CHD, as recently described by Farooqi et al (20) and
Saeed et al. (45). 3D printing can also assist with
transplant planning for recipients with complex CHD,
as in the following case. Figures 9A to 9C show a
22-year-old male patient with heterotaxy syndrome,
unbalanced atrioventricular canal, L-looped
FIGURE 7 Simulated Surgery for Complex Total Cavopulmonary Connection Planning Using Flexible, Intact-Heart Model
See Supplemental Video 1. LPA ¼ left pulmonary artery; RPA ¼ right pulmonary artery; RSVC ¼ right superior vena cava; other abbreviations
as in Figures 5 and 6.
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FIGURE 8 Staged Repair of Tetralogy of Fallot, Pulmonary Atresia, and MAPCAs
(A) Pre-operative anatomy. (B) Unifocalization of right-sided major aortopulmonary collateral arteries (MAPCAs) and small right pulmonary
artery (PA)–to–right modiﬁed Blalock-Taussig-Thomas shunt. (C) Use of 3D model in the operating room for procedural guidance. (D)
Unifocalization of left-sided major aortopulmonary collateral arteries–to–left modiﬁed Blalock-Taussig-Thomas shunt. (E) Right ventricular
(RV)–to–pulmonary artery conduit placement (green) to unifocalized major aortopulmonary collateral arteries and takedown of bilateral
modiﬁed Blalock-Taussig-Thomas shunts. APC ¼ aortopulmonary collateral; LSCA ¼ left subclavian artery; PTFE ¼ polytetraﬂuoroethylene;
SVC ¼ superior vena cava.
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ventricles (ventricular inversion), and pulmonary
atresia. He had undergone 6 prior sternotomies
including ASD and VSD closure, culminating in a
unique modiﬁed Fontan procedure with a left ven-
tricular (pulmonic ventricle)–to–left superior vena
cava conduit after thrombosis of his right-sided Glenn
procedure. More recently, a Melody valve was placed
in a left ventricular–to–left superior vena cava
conduit for conduit stenosis. He presented with se-
vere protein-losing enteropathy and heart failure.
Given the patient’s debilitated state and multiple
prior sternotomies, he was deemed a very high
FIGURE 9 Heterotaxy, Unbalanced Atrioventricular Canal, Ventricular Inversion, Modiﬁed Fontan
(A) 3D model showing a left ventricle (LV)–to–left superior vena cava (LSVC) conduit and left-sided Glenn procedure that complicates transplantation of a normal donor
heart. (B) Intracardiac anatomy. (C) Intraoperative ﬁndings: explanted heart and a left ventricle–to–left superior vena cava conduit, showing accuracy of the 3D model.
ASD ¼ atrial septal defect; other abbreviations as in Figures 6 and 7.
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surgical risk for cardiac transplantation. 3D printing
was performed to plan key components of the trans-
plant, including thoracic entry, cannulation options,
conduct of bypass, and graft-donor connections. 3D
printing for transplant planning has been previously
described for patients with complex pre-transplant
anatomy (46,47).
AIRWAY ABNORMALITIES. In CHD cases, the airways
may be involved in the pathophysiology or need to be
accounted for in surgical planning, as demonstrated
earlier in the case with tetralogy of Fallot with pul-
monary atresia and MAPCAs. In some CHD lesions,
airways may be directly affected by the cardiovascu-
lar disease. Examples include vascular rings
(Figure 10A), where aberrant vessels cause airway
compression, or compression from dilated pulmonary
arteries in tetralogy of Fallot with absent pulmonary
valve (Figure 10B).
Airway compression or tracheobronchomalacia can
signiﬁcantly add to morbidity of patients with CHD
from prolonged ventilator dependence. 3D printing
recently led to a momentous breakthrough in the
management of these patients with the use of 3D
printed bioresorbable airway splints (48,49). Pilot
data from 4 patients are shown in Figure 11. In this
series 3D printed splints were implanted without
complications and resulted in patency of the airway.
If successful in larger cohorts, this application of 3D
printing will dramatically change the management
and outcomes for these challenging patients. Other
applications of 3D printing in otolaryngology and
airway abnormalities were recently reviewed by
VanKoevering et al. (17).
CATHETER-BASED INTERVENTIONS. 3D printing has
been used for catheter-based interventions in CHD,
although to a lesser degree compared with cardiotho-
racic surgery. Some noteworthy applications include
the following: percutaneous pulmonary valve im-
plantation, reported as early as 2007 (50); coarctation
procedures (51); and stenting for aortic arch hypoplasia
(52). Other reported applications include transcatheter
ASD closure (29), double-lobed left atrial appendage
closure (53), caval valve implantation (54), and stent-
ing of Mustard bafﬂe obstruction (55). 3D printing is of
particular interest in noncongenital structural heart
disease, including transcatheter mitral and aortic
valve interventions (56–58). Potential beneﬁts in
interventional cardiology include visualization of
complex anatomy that leads to decreased radiation
and contrast from ﬂuoroscopy and angiography and
improved procedural outcome. Other beneﬁts may
include device development and testing in models
that replicate abnormal anatomy (59). Finally, a key
beneﬁt may be feasibility testing for complex or
borderline cases, as in the case of this 15-year-old
male patient from our institution with repaired
tetralogy of Fallot who met the criteria for pulmonary
valve replacement (Figure 12). MRI measurements
indicated that his right ventricular outﬂow tract
dimensions were borderline large for transcatheter
pulmonary valve replacement; thus, a 3D model was
made in ﬂexible material to trial pre-stenting as a
precursor to transcatheter pulmonary valve replace-
ment. The 3D model showed feasibility of the
catheter-based strategy, and the procedure was
carried out, with subsequent successful implantation
of a transcatheter pulmonary valve, thereby avoiding
surgery.
Impediments to greater use of 3D models in
catheter-based procedures include tissue character-
istics of the models that do not respond to balloons
and stents in the same way as native tissue. More-
over, current models do not reﬂect the physiological
environment encountered during catheterization,
with nonpulsatility a major limitation of static
models. Both these limitations may be overcome with
future iterations of 3D models, as discussed later in
this article.
ADULTS WITH CONGENITAL HEART DISEASE.
Approximately 85% of children with CHD now survive
into adulthood (60), and adults with CHD (ACHD)
now outnumber children (61). There are an estimated
5 million adult survivors in the United States alone
(62,63). Over the past few decades the proportion of
all deaths in patients with CHD has shifted from in-
fants to the ACHD population (64). Similar to their
pediatric counterparts, risk factors that worsen ACHD
outcomes include complex anatomy, prior surgeries,
and length of time spent on cardiopulmonary bypass
(65–67). Although the challenges involving complex
ACHD are considerable, 3D printing may help in their
management by applications described in prior sec-
tions and in recent publications (20,25,26,68,69).
Representative cases are shown in Figures 13A to 13D,
as previously described (68).
ACCURACY AND QUALITY ASSURANCE IN
CARDIAC 3D PRINTING
Accuracy in medical 3D printing is of paramount
importance, although published reports on this topic
are limited. Accuracy is deﬁned by comparison with a
gold standard, and in the case of 3D printed models,
1 metric of accuracy is comparison with operative
ﬁndings. At our institution, the quality assurance
process is driven by feedback from our surgical
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FIGURE 10 Airway Abnormalities in Congenital Heart Disease
(A) Vascular ring with posterior compression of trachea by a circumﬂex transverse arch coursing behind the aorta. (B) Severe branch
pulmonary artery dilation in tetralogy of Fallot with absent pulmonary valve with compression and malacia of bilateral mainstem bronchi.
Abbreviations as in Figure 7.
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FIGURE 11 Bioresorbable Airway Splint Manufactured From Polycaprolactone With a Bellowed Design to Promote Expansion and Growth Over Time
Reproduced with permission from Morrison et al. (48).
FIGURE 12 3D Printed Model in a Case of TOF With Borderline Large PA Measurements
Image on the left shows a stent within main pulmonary artery (MPA). Image on the right is an angiogram taken after successful transcatheter
implantation of pulmonary valve. PA ¼ pulmonary artery; TOF ¼ tetralogy of Fallot.
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colleagues and ﬁndings in the OR. Between February
2015 and May 2017, the average accuracy score for 21
3D printed models at our institution was 4 of a
possible 5 points when the surgeon compared model
anatomy with ﬁndings in the OR. A similar quality
assurance process was described by Hermsen et al.
(70) for surgical models of hypertrophic obstructive
cardiomyopathy. We have found that direct and
ongoing communication among the imaging,
modeling, and surgical teams is essential for main-
taining high levels of accuracy. In addition, model
accuracy may be diminished if there is a signiﬁcant
delay between acquisition of source images and time
of surgery. In infants and young children somatic
growth and evolution of the pathophysiology can
produce relatively large changes to the anatomy as
time passes; thus, the pre-operative imaging and 3D
modeling should be performed close to the time of
anticipated surgery.
Besides direct comparison with OR ﬁndings, other
metrics of accuracy include comparison with source
images and user feedback. Olivieri et al. (71) reported
that 3D printed models from echocardiographic data
were comparable in measurements of VSDs when
compared with source images. Yoo et al. (72) reported
data from 50 surgeons after undergoing a Hands-on
FIGURE 13 3D Models of Adults With Congenital Heart Disease
(A) A 31-year-old patient with dextrocardia, a double-outlet right ventricle (DORV), and a Fontan procedure. (B) A 19-year-old patient with a bicuspid aortic valve (not
shown) and a severely dilated aortic root and ascending aorta. (C) A 40-year-old patient with a double-outlet right ventricle, 2 VSDs, and classic Glenn and modiﬁed
Mustard procedures (conduit from inferior vena cava [IVC] to left atrium [LA], in green). (D) A 45-year-old patient with a left dominant unbalanced atrioventricular canal,
a double-outlet right ventricle, and right ventricular outﬂow tract obstruction. Abbreviations as in Figures 5 to 8. Reproduced with permission from Anwar et al. (68).
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Surgical Training course using 3D models. The ma-
jority of cardiothoracic surgeons reported that the 3D
models were of “excellent” or “good” quality for
surgical simulation (72). Finally, accuracy of 3D
models may be judged in terms of their ability to
recreate native physiology, not just anatomy. The
innovative work of Vukicevic et al. (4) has shown the
ability to recreate “hemodynamics” of abnormal
aortic valves in 3D models, with Doppler character-
istics nearly identical to those of the patient’s own
diseased valve (Figure 14).
3D PRINTING FOR TRAINEE EDUCATION AND
SURGICAL SIMULATION
Another arena where 3D printing can bring about
transformative change is in the education and training
of the next generation of physicians. This is an
established practice in neurosurgery (73,74) and
otolaryngology (17), with more recent application in
cardiology (75–78). Although medical training has long
followed the practice of “see 1, do 1, teach 1,” use of 3D
models in education represents a paradigm shift from
an apprenticeshipmodel to a simulator-based learning
method that complements traditional mentored
training (79,80). 3D models in CHD can reduce the
learning curve for cardiac trainees in 3 key areas:
1. Understanding complex 3D anatomy
2. High-ﬁdelity simulation experiences
3. Exposure to rare cases
As a tool for surgical simulation, 3D printing has
been applied toward septal myectomy for hypertro-
phic obstructive cardiomyopathy (70), vascular pro-
cedures (76,77,81), and complex congenital
procedures, as described by Yoo et al. (72) (Figure 15).
FIGURE 14 Patient and Model Doppler Comparisons
Doppler proﬁle of a patient’s echocardiogram on the left, compared with the Doppler image from the 3D printed model on the right. Arrows
point towards the aortic valve from the patient’s echocardiogram (left) and model (right). Adapted with permission from Vukicevic et al. (4).
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In addition to allowing practice on highly accurate
simulators, the 3D models expose trainees to patho-
logical features they may rarely encounter. This shifts
the practice of surgery from an “opportunity-based”
(26) to a “curriculum-based” experience. For experi-
enced practitioners, models may be used for lifelong
learning, for maintenance of certiﬁcation, or for
practice before challenging cases. Thus, a repository of
3D printed cardiovascular models with the spectrum
of CHDwould be an ideal educational resource (82,83).
The 3D print Heart Library at the National Institutes of
Health (84) is a good example of this concept. Elec-
tronic 3D models may supplement traditional learning
methods, and an example is shown in Supplemental
Video 2 (Figure 15). Finally, virtual reality displays
may be used as complementary platforms to interact
with electronic 3D models, with several robust options
currently available (25,85).
3D PRINTING TO FACILITATE
COMMUNICATION WITHIN THE
MEDICAL TEAM AND FOR COUNSELING
PATIENTS AND FAMILIES
Cardiac surgery and perioperative care are conducted
in a multidisciplinary setting requiring highly skilled
and specialized teams. Communication among spe-
cialists is essential for avoiding errors and optimizing
patient outcomes (86–88). 3D models provide clarity,
and they are cornerstones around which multiple
subspecialists can gather to discuss the pathological
condition, surgical plan, anticipated outcomes, and
perioperative care. In so doing, they may reduce
medical errors, a postulate that deserves further
investigation.
In addition to facilitating communication among
medical team members, 3D models enable better
communication between the medical team and
patients or their caregivers (51,89,90). The models can
help the patient or caregiver better understand the
disease process, risks, beneﬁts, and alternatives.
Anecdotally, our institutional practice is to counsel
patients and families by using 3D models if a model
has been printed for a case. Eleven caregivers who
completed a questionnaire for cardiac models be-
tween 2014 and 2017 reported that the models were
“very helpful” (score 5 of 5) to improve understanding
of the anatomy. Similarly, Biglino et al. (75) reported
that 3D models could help improve the family’s
experience with medical care when models were used
for counseling. More data are needed on the poten-
tially powerful impact of 3D printing in patient and
family education and shared decision making.
ADVANCED APPLICATIONS AND
FUTURE DIRECTIONS
3D printing is rapidly evolving in medicine, with
technical improvements in printers and software
fueling new and exciting applications in patient care,
innovation, and research. In cardiovascular medicine,
a major limitation is high-resolution printing of
structures currently not well resolved by CT or MRI,
such as atrioventricular valves (91) or the atrial
septum. 3D printing from 3D echocardiography could
potentially overcome these limitations, with some
promising early results (92–96). 3D printing from
angiographic imaging could expand options,
currently largely unexplored (97). The next evolution
in 3D printing would be “multimodality” printing,
with a model created by combining key elements of
the anatomy from different imaging modalities. True
co-registration of a highly accurate dataset is a tech-
nical challenge, and there are some early feasibility
data (98,99).
In addition to advances in 3D dataset acquisition
and post-processing, the next major step forward in
3D printing will likely be driven by improvements in
printer technology and print materials. “Tissue
mimicking” materials currently under development
(100,101) would enable the creation of more life-like
models that replicate the patient’s unique anatomy
FIGURE 15 Simulated Arterial Switch Operation From a
Hands-on Surgical Training Course for Cardiothoracic
Surgeons
Reproduced with permission from Yoo et al. (72). See
Supplemental Video 2. LCA ¼ left coronary artery; other
abbreviations as in Figures 5 and 6.
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and physiology. Currently there are highly accurate
noninvasive methods to assess cardiac function and
blood ﬂow (102), including methods to assess 3D in-
formation over the cardiac cycle, thereby providing
“4D” function and ﬂow. These multivariate datasets
could be integrated into 3D models to build holistic
models to advance our understanding of cardiac dis-
ease. As 3D models achieve more realistic states, they
may be used to study pathophysiology, predict long-
term outcomes, and choose optimal treatment plans
or surgical repairs (58,103–107). Recent studies have
analyzed blood ﬂow in deformable models (108,109),
including ﬂow characteristics in patients with hypo-
plastic left heart syndrome following Norwood arch
reconstruction (75,110).
Finally, bioprinting offers the potential to make
the leap from printing “life-like” to living tissue itself.
This revolutionary technology is in its infancy; how-
ever, several techniques now exist that can deposit
bioinks in precise locations to build up complex tissue
constructs (111). Bioprinting has been applied to print
anatomically shaped cartilage structures (112), skin
(113,114), implants for bone growth (115), and even a
3D printed “bionic ear” (116). Within cardiology, re-
searchers have reported techniques to print vascula-
ture, myocardium, and valves (117–121). These
applications and bioprinting techniques were
recently reviewed by Duan. (111).
Although current and future applications of 3D
printing are exciting and potentially game-changing,
broad adoption is currently hampered by the costs of
modeling and printing. The cost of a 3D printing
center to a medical program is considerable, and at
minimum it includes the cost of segmentation soft-
ware, a medical-grade 3D printer, material costs, and
personnelwith 3D printing expertise. Some of the costs
may be lowered by printing off-site through commer-
cial vendors, although with inherent trade-offs in
long-term costs and turn-around time. These are
evolving issues, and the ultimate viability of medical
3D printing will in large part depend on the impact
it has on improving patient care.
CONCLUSIONS
3D printing is a transformative technology that is
affecting key aspects of CHD care. As a planning and
simulation tool, if offers the promise of more precise
surgery with fewer complications. For training, 3D
models can reduce the learning curve and increase
opportunities for procedural practice. The models can
facilitate communication among multidisciplinary
teams, thus potentially reducing medical errors. They
can increase engagement of patients and families,
thereby enhancing shared decision making. Finally,
3D models can lead to medical breakthroughs by
enabling basic science, translational, and clinical in-
vestigations. More data are needed to quantify these
potential beneﬁts from 3D printing, and the early
experience is promising.
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